quinaprilat has been researched along with angiotensin ii in 16 studies
| Studies (quinaprilat) | Trials (quinaprilat) | Recent Studies (post-2010) (quinaprilat) | Studies (angiotensin ii) | Trials (angiotensin ii) | Recent Studies (post-2010) (angiotensin ii) |
|---|---|---|---|---|---|
| 92 | 23 | 4 | 38,152 | 1,089 | 7,413 |
| Protein | Taxonomy | quinaprilat (IC50) | angiotensin ii (IC50) |
|---|---|---|---|
| Atrial natriuretic peptide receptor 3 | Homo sapiens (human) | 0.002 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.002 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0018 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0055 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.004 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (50.00) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Boscaro, M; D'Agostino, D; Fallo, F; Mantero, F; Pedini, F; Pistorello, M | 1 |
| Bara, AT; Busse, R; Hecker, M; Pörsti, I | 1 |
| Fritschka, E; Wolter, K | 1 |
| Bumpus, FM; Husain, A; Kinoshita, A; Urata, H | 1 |
| Bakovic-Alt, R; Bonzel, T; Mitrovic, V; Mudra, H; Posvar, EL; Schmidt, W; Strand, JC | 1 |
| Cuche, JL; Guérin, AP; London, GM; Marchais, SJ; Pannier, B; Safar, ME; Vicaut, E | 1 |
| Bonzel, T; Mitrovic, V; Mudra, H; Schlepper, M; Schmidt, W | 1 |
| Allegrini, PR; Buser, PT; Hornstein, PS; Zaugg, CE; Zhu, P | 1 |
| de Haan, CH; de Leeuw, PW; Fuss-Lejeune, MJ; Houben, AJ; Kroon, AA | 1 |
| Danser, AH; de Vries, R; Saxena, PR; Schalekamp, MA; Schuijt, MP | 1 |
| Demir, S; Hempelmann, G; Kwapisz, MM; Müller, M; Roth, P; Schindler, E; Veit, M | 1 |
| Faramarzi, S; Grimm, D; Grosse, J; Habighorst, B; Infanger, M; J Danser, AH; Kossmehl, P; Kreutz, R; Kurth, E; Paul, M; Shakibaei, M; Wehland, M | 1 |
| de Bruin, RJ; Deinum, J; Dive, V; Hectors, M; Jan Danser, AH; Montgomery, HE; Payne, JR; van Esch, JH; van Gool, JM | 1 |
| Cosentino, F; Delli Gatti, C; Eto, M; Kouroedov, A; Lüscher, TF; Osto, E; Shaw, S; Volpe, M | 1 |
| Briggs, JP; Chen, L; Chen, M; Eisner, C; Gomez, RA; Huang, Y; Kim, SM; Li, L; Mizel, D; Oppermann, M; Schnermann, J; Sequeira Lopez, ML; Weinstein, LS | 1 |
| Balachandran, K; Ozkizilcik, A; Patel, S; Sysavanh, F; Tandon, I | 1 |
5 trial(s) available for quinaprilat and angiotensin ii
| Article | Year |
|---|---|
Hemodynamic and hormonal effects of quinaprilat in patients with congestive heart failure.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Isoquinolines; Male; Middle Aged; Peptidyl-Dipeptidase A; Renin; Tetrahydroisoquinolines | 1996 |
Antihypertensive effects and arterial haemodynamic alterations during angiotensin converting enzyme inhibition.
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteries; Blood Pressure; Female; Hemodynamics; Humans; Hypertension; Isoquinolines; Kidney Failure, Chronic; Male; Middle Aged; Tetrahydroisoquinolines | 1996 |
[Hemodynamic and humoral effects of parenteral therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure].
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Catecholamines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Heart Failure; Hemodynamics; Hormones; Humans; Infusions, Intravenous; Isoquinolines; Male; Middle Aged; Peptidyl-Dipeptidase A; Renin; Tetrahydroisoquinolines | 1996 |
Quinaprilat-induced vasodilatation in forearm vasculature of patients with essential hypertension: comparison with enalaprilat.
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Enalaprilat; Forearm; Heart Rate; Humans; Hypertension; Isoquinolines; Male; Middle Aged; Peptidyl-Dipeptidase A; Regional Blood Flow; Tetrahydroisoquinolines; Vasodilation | 2000 |
The effect of intravenous quinaprilat on plasma cytokines and hemodynamic variables during cardiac surgery.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiac Output; Coronary Artery Bypass; Cytokines; Double-Blind Method; Female; Hemodynamics; Humans; Injections, Intravenous; Interleukin 1 Receptor Antagonist Protein; Interleukin-10; Isotonic Solutions; Male; Middle Aged; Prospective Studies; Sialoglycoproteins; Sodium Chloride; Tetrahydroisoquinolines; Time Factors; Tumor Necrosis Factor-alpha | 2004 |
11 other study(ies) available for quinaprilat and angiotensin ii
| Article | Year |
|---|---|
In vitro evidence for local generation of renin and angiotensin II/III immunoreactivity by the human adrenal gland.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aged; Aldosterone; Angiotensin II; Angiotensin III; Female; Humans; Immunoradiometric Assay; In Vitro Techniques; Isoquinolines; L-Lactate Dehydrogenase; Male; Middle Aged; Radioimmunoassay; Renin; Tetrahydroisoquinolines; Time Factors | 1991 |
Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor.
Topics: Amino Acid Sequence; Angiotensin I; Angiotensin II; Animals; Arginine; Bradykinin; Coronary Vessels; Endothelium, Vascular; In Vitro Techniques; Isoquinolines; Molecular Sequence Data; Muscle Relaxation; Nitric Oxide; Nitroarginine; Peptide Fragments; Receptors, Angiotensin; Swine; Tetrahydroisoquinolines; Vasodilator Agents | 1994 |
Pharmacokinetics and pharmacodynamics of quinaprilat after low dose quinapril in patients with terminal renal failure.
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Female; Humans; Isoquinolines; Kidney Failure, Chronic; Male; Middle Aged; Peptidyl-Dipeptidase A; Peritoneal Dialysis, Continuous Ambulatory; Quinapril; Renal Dialysis; Tetrahydroisoquinolines | 1993 |
Measurement of angiotensin I converting enzyme inhibition in the heart.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Captopril; Cricetinae; Dipeptides; Enalaprilat; Humans; Isoquinolines; Lisinopril; Male; Mesocricetus; Papillary Muscles; Tetrahydroisoquinolines | 1993 |
Bradykinin-dependent cardioprotective effects of losartan against ischemia and reperfusion in rat hearts.
Topics: Adenosine Triphosphate; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Coronary Circulation; In Vitro Techniques; Isoquinolines; Losartan; Male; Myocardial Reperfusion Injury; Myocardium; Phosphocreatine; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrahydroisoquinolines; Ventricular Function, Left; Ventricular Pressure | 1999 |
Vasoconstriction is determined by interstitial rather than circulating angiotensin II.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Carotid Arteries; Dose-Response Relationship, Drug; Femoral Artery; Imidazoles; In Vitro Techniques; Irbesartan; Isoquinolines; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Swine; Tetrahydroisoquinolines; Tetrazoles; Vasoconstriction; Vasoconstrictor Agents | 2002 |
Mechanisms of apoptosis after ischemia and reperfusion: role of the renin-angiotensin system.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Shape; fas Receptor; Female; Heart; Myocardial Infarction; Myocardium; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Random Allocation; Renin-Angiotensin System; Reperfusion Injury; Swine; Tetrahydroisoquinolines; Tumor Suppressor Protein p53 | 2006 |
Different contributions of the angiotensin-converting enzyme C-domain and N-domain in subjects with the angiotensin-converting enzyme II and DD genotype.
Topics: Adult; Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Coronary Vessels; Enzyme Activation; Female; Genotype; Humans; In Vitro Techniques; Male; Middle Aged; Oligopeptides; Peptidyl-Dipeptidase A; Phosphinic Acids; Point Mutation; Protein Structure, Tertiary; Sus scrofa; Tetrahydroisoquinolines; Vasoconstrictor Agents; Vasodilator Agents | 2008 |
Pulsatile stretch induces release of angiotensin II and oxidative stress in human endothelial cells: effects of ACE inhibition and AT1 receptor antagonism.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomechanical Phenomena; Cells, Cultured; Endothelial Cells; Hemorheology; Humans; Losartan; Models, Biological; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Pulsatile Flow; Renin-Angiotensin System; Stress, Mechanical; Superoxides; Tetrahydroisoquinolines | 2008 |
Stimulation of renin secretion by angiotensin II blockade is Gsalpha-dependent.
Topics: Adenylyl Cyclases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Captopril; Catecholamines; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enalapril; Female; GTP-Binding Protein alpha Subunits, Gs; Juxtaglomerular Apparatus; Male; Mice; Mice, Knockout; Models, Animal; Nitric Oxide; Prostaglandins; Renin; Signal Transduction; Tetrahydroisoquinolines; Tetrazoles | 2010 |
Local Renin-Angiotensin System Signaling Mediates Cellular Function of Aortic Valves.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve; Cells, Cultured; Fluorescent Antibody Technique; Losartan; Myofibroblasts; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Swine; Tetrahydroisoquinolines | 2021 |